The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  Kuznetsov, Sergey ^a   Khoklatchev, Andrei V ^b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 5; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CALCIUM; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RASSF1 PROTEIN, HUMAN; RASSF5 PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN TARGETING; TISSUE CULTURE; TUMOR ESCAPE; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CALCIUM; CALPAIN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; MONOMERIC GTP-BINDING PROTEINS; NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 58049194223     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003997     Document Type: Article

References (34)

1. Vavvas D, Li X, Avruch J, Zhang XF (1998) Identification of Nore1 as a potential Ras effector. J Biol Chem 273: 5439-5442.
2. Stieglitz B, Bee C, Schwarz D, Yildiz O, Moshnikova A, et al. (2008) Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II. Embo J 27: 1995-2005.
3. van der Weyden L, Adams DJ (2007) The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776: 58-85.
4. Hesson L, Dallol A, Minna JD, Maher ER, Latif F (2003) NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 22: 947-954.
5. Tommasi S, Dammann R, Jin SG, Zhang XF, Avruch J, et al. (2002) RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Oncogene 21: 2713-2720.
6. Aoyama Y, Avruch J, Zhang XF (2004) Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases. Oncogene 23: 3426-3433.
7. Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ (2003) The pro-apoptotic Ras effector Nore1 may serve as a Ras regulated tumor suppressor in the lung. J Biol Chem 278: 21938-21943.
8. Moshnikova A, Frye J, Shay JW, Minna JD, Khokhlatchev AV (2006) The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. J Biol Chem 281: 8143-8152.
9. Dammann R, Schagdarsurengin U, Strunnikova M, Rastetter M, Seidel C, et al. (2003) Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol 18: 665-677.
10. Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP (2003) Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 22: 8125-8136.
11. Dammann R, Li C, Yoon JH, Chin PL, Bates S, et al. (2000) Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319.
12. Donninger H, Vos MD, Clark GJ (2007) The RASSF1A tumor suppressor. J Cell Sci 120: 3163-3172.
13. van der Weyden L, Tachibana KK, Gonzalez MA, Adams DJ, Ng BL, et al. (2005) The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis. Mol Cell Biol 25: 8356-8367.
14. Tommasi S, Dammann R, Zhang Z, Wang Y, Liu L, et al. (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92-98.
15. Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, et al. (2005) The Ras Effector NORE1A is Suppressed in Follicular Thyroid Carcinomas with a PAX8-PPAR {gamma} Fusion. J Clin Endocrinol Metab.
16. Pan ZG, Kashuba VI, Liu XQ, Shao JY, Zhang RH, et al. (2005) High frequency somatic mutations in RASSF1A in nasopharyngeal carcinoma. Cancer Biol Ther 4: 1116-1122.
17. Harjes E, Harjes S, Wohlgemuth S, Muller KH, Krieger E, et al. (2006) GTP-Ras Disrupts the Intramolecular Complex of C1 and RA Domains of Nore1. Structure 14: 881-888.
18. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, et al. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699.
19. Goll DE, Thompson VF, Li H, Wei W, Cong J (2003) The calpain system. Physiol Rev 83: 731-801.
20. Demarchi F, Schneider C (2007) The calpain system as a modulator of stress/damage response. Cell Cycle 6: 136-138.
21. Carragher NO, Frame MC (2002) Calpain: a role in cell transformation and migration. Int J Biochem Cell Biol 34: 1539-1543.
22. Carragher NO, Fonseca BD, Frame MC (2004) Calpain activity is generally elevated during transformation but has oncogene-specific biological functions. Neoplasia 6: 53-73.
23. Hiwasa T, Nakata M, Ohno S, Maki M, Suzuki K, et al. (2002) Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts. Biochem Biophys Res Commun 290: 510-517.
24. 2+-Dependent Neutral Protease (Calpain) Activity in Breast Cancer Tissue and Estrogen Receptor Status. Breast Cancer 3: 13-17.
25. Shiba E, Kim S, Fujitani M, Kambayashi JI, Kawamura I, et al. (1996) Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells. Anticancer Res 16: 773-777.
26. Joy J, Nalabothula N, Ghosh M, Popp O, Jochum M, et al. (2006) Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d). Biol Chem 387: 329-335.
27. Delmas C, Aragou N, Poussard S, Cottin P, Darbon JM, et al. (2003) MAP kinase-dependent degradation of p27Kip1 by calpains in choroidal melanoma cells. Requirement of p27Kip1 nuclear export. J Biol Chem 278: 12443-12451.
28. Kubbutat MH, Vousden KH (1997) Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 17: 460-468.
29. Munarriz E, Bano D, Sayan AE, Rossi M, Melino G, et al. (2005) Calpain cleavage regulates the protein stability of p73. Biochem Biophys Res Commun 333: 954-960.
30. Kimura Y, Saya H, Nakao M (2000) Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas. Neuropathology 20: 153-160.
31. Atencio IA, Ramachandra M, Shabram P, Demers GW (2000) Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines. Cell Growth Differ 11: 247-253.
32. Tonnetti L, Netzel-Arnett S, Darnell GA, Hayes T, Buzza MS, et al. (2008) SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. Cancer Res 68: 5648-5657.
33. Darnell GA, Schroder WA, Antalis TM, Lambley E, Major L, et al. (2007) Human papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein. J Biol Chem 282: 37492-37500.
34. Khokhlatchev A, Rabizadeh S, Xavier R, Nedwidek M, Chen T, et al. (2002) Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 12: 253-265.